Harry L. Leider - May 6, 2022 Form 4 Insider Report for GELESIS HOLDINGS, INC. (GLSH)

Role
Chief Medical Officer
Signature
/s/ David Abraham, Attorney-in-Fact
Stock symbol
GLSH
Transactions as of
May 6, 2022
Transactions value $
$0
Form type
4
Date filed
5/9/2022, 04:17 PM
Previous filing
Jan 24, 2022
Next filing
Jun 9, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction GLSH Common Stock Award +10.2K 10.2K May 6, 2022 Direct F1, F2
transaction GLSH Common Stock Award +34.3K +337.13% 44.4K May 6, 2022 Direct F1, F3
transaction GLSH Common Stock Award +270K +606.93% 314K May 6, 2022 Direct F1, F4

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GLSH Stock Option (Right to Buy) Award $0 +270K $0.00 270K May 6, 2022 Common Stock 270K $3.33 Direct F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units ("RSUs"). Each RSU represents the contingent right to receive one share of the Issuer's common stock upon vesting and settlement.
F2 These RSUs vest in full on February 8, 2023, subject to the reporting person's continued service at such time.
F3 These RSUs vest in full on February 15, 2023, subject to the reporting person's continued service at such time.
F4 25% of these RSUs shall vest on April 1, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.
F5 25% of the shares underlying this option shall vest and become exercisable on March 4, 2023, with the remainder vesting in twelve (12) equal quarterly installments thereafter, subject to the reporting person's continued service on each such vesting date.